Tianjin Conjustar Biotechnology Co., Ltd.-Investor Relations

History of financing

The company was jointly incubated by Fosun Health Capital New Drug Fund and WuXi AppTec and has completed USD ~27 million in seed, angel &pre-A round financing.

Investor

DOSUN HEALTH CAPITAL

With the continuous development of the company, we have won the favor of many partners.With the continuous development of the company, we have won the favor of many partners.With the continuous development of the company, we have won the favor of many partners.With the continuous development of the company, we have won the favor of many partners.

MORE+

DOSUN HEALTH CAPITAL

With the continuous development of the company, we have won the favor of many partners.With the continuous development of the company, we have won the favor of many partners.With the continuous development of the company, we have won the favor of many partners.With the continuous development of the company, we have won the favor of many partners.

MORE+

DOSUN HEALTH CAPITAL

With the continuous development of the company, we have won the favor of many partners.With the continuous development of the company, we have won the favor of many partners.With the continuous development of the company, we have won the favor of many partners.With the continuous development of the company, we have won the favor of many partners.

MORE+

DOSUN HEALTH CAPITAL

With the continuous development of the company, we have won the favor of many partners.With the continuous development of the company, we have won the favor of many partners.With the continuous development of the company, we have won the favor of many partners.With the continuous development of the company, we have won the favor of many partners.

MORE+

DOSUN HEALTH CAPITAL

With the continuous development of the company, we have won the favor of many partners.With the continuous development of the company, we have won the favor of many partners.With the continuous development of the company, we have won the favor of many partners.With the continuous development of the company, we have won the favor of many partners.

MORE+